Gain Therapeutics, Inc.GANXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-4.1%
5Y CAGR+46.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-4.1%/yr
vs +157.0%/yr prior
5Y CAGR
+46.9%/yr
Recent deceleration
Acceleration
-161.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
6.8x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.54M | -10.6% |
| 2024 | $9.56M | -11.4% |
| 2023 | $10.79M | +11.4% |
| 2022 | $9.68M | +41.6% |
| 2021 | $6.84M | +447.4% |
| 2020 | $1.25M | +125.0% |
| 2019 | $555165.00 | +150.0% |
| 2018 | $222047.00 | - |